MedTrace Logo

Efficacy of Re-challenge With Immune-Checkpoints Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients: a Retrospective Observational Study

NCT04069663 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 144

Last updated 2020-03-30

No results posted yet for this study

Summary

This is a multicentre, retrospective, national observational study aiming to describe clinical outcomes of advanced NSCLC patients that performed an ICP re-challenge during their history of disease. The objective of this study is to evaluate the ICP re-challenge efficacy.

Conditions

  • Non Small Cell Lung Cancer

Interventions

OTHER

No interventional study

Retrospective data analysis

Sponsors & Collaborators

Principal Investigators

  • Elisa Gobinni, MD · University Hospital, Grenoble

  • Matteo Giaj Levra, pHD · University Hospital, Grenoble

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-22
Primary Completion
2019-05-15
Completion
2019-10-15

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04069663 on ClinicalTrials.gov